PHARMAC seminar: Dermatology update, acute rashes part 1

(30:15)

PHARMAC seminar: Managing neonate complications - part 1

(40:12)

PHARMAC seminar: Smokefree 2025, 1 of 6. Engaging and motivating smokers to quit

(21:48)

PHARMAC seminar: Managing polypharmacy, 1a of 4: Introduction, pt1

(25:2)

PHARMAC seminar: Women's health 2019, 1b of 6, amenorrhea

(17:26)

PHARMAC seminar: Addressing health inequity for tāne Māori, 1b of 5, overview of the issues

(33:8)

PHARMAC seminar: Managing polypharmacy, 1b of 4: Introduction, pt2

(26:35)

PHARMAC seminar: Women's health 2019, 5b of 6, menopause and menopausal hormone therapy

(33:30)

Training Session- Community Pharmacy/Retail

(31:11)

Mankind Pharma: Fundamental Analysis | Stocks in Focus - Part 3 | CA Rachana Ranade

(14:59)

Free YouTube Batch for Pharma Students! अब होगी तैयारी और भी आसान! 🎯🔥#pwpharma #pw #gpat

(28:21)

Launching @PWPharma for GPAT \u0026 NIPER, Government Vacancy Exams \u0026 DPEE Exit Exam

(27:30)

GPAT 2025 Pharmacology | Basic concepts of Pharmacology | PW

(1:8:23)

PCI new Notification for all pharmacy students and Instituitions

(16:5)

FMGE, June 2025 Detailed Strategy to Cross 200 marks with Dr. Gobind Rai Garg \u0026 Dr. Praveen Tripathi

(39:33)

What are the Syptoms of Withdrawal?

(9:55)

Utkarsh Odisha - Make in Odisha Conclave 2025 | Sectoral Session on Healthcare, Pharma \u0026 Biotech

(2:24)

PHARMAC seminar: Addressing health inequity for tāne Māori 1 of 5, overview of the issues

(27:49)

PHARMAC seminar: Smokefree 2025, 4 of 6. Developing QUIT plans, when things go \

(39:28)

PHARMAC seminar: Women's health 2019, 1a of 6, amenorrhea

(25:12)

PHARMAC seminar: Ear, nose and throat (ENT) update, 2 of 5. Chronic rhinosinusitis

(18:57)

PHARMAC seminar: Women's health 2019, 4 of 6, Premature ovarian insufficiency

(20:29)

PHARMAC Seminar Series: Dermoscopy, 1a of 5. Introduction to dermatoscopy - part 1

(27:15)

PHARMAC seminar: Women's health 2019, 2 of 6, hypothalamic amenorrhea

(31:52)

Introducing PHARMAC’s Factors for Consideration

(4:22)